Global Biological Safety Testing Market to Reach US$ 7.16 Billion by 2027, Impelled by Significant Growth in Pharmaceutical Industry

September 19, 2022

According to the latest report by IMARC Group, titled “Biological Safety Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global biological safety testing market reached a value of US$ 3.51 Billion in 2021. Biological safety testing ensures the non-contamination of biopharmaceuticals, medicines, and laboratories. It includes endotoxin, sterility, cell line authentication and characterization, bioburden tests, and adventitious agent detection as standard tests. It is widely conducted to assure contamination-free biopharmaceutical products such as vaccines, drugs, therapeutics, blood-derived products, stem cells, tissue banks, and other biologics.  Biological safety testing ensures that all biological materials, across the development process, are safe, free of contaminants, characterized, and meet regulatory compliances. It assists in reducing risk and exposure to toxic and harmful elements and decontamination of medical equipment, laboratories, and healthcare institutions.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Biological Safety Testing Market Trends:

The significant growth in the pharmaceutical industry across the globe is creating a positive outlook for the market.  Biological safety testing helps ehance manufacturing effectiveness by assessing the safety of targeted and specific therapies, circumventing potential shortcomings, and evaluating their outcomes. Additionally, the increasing demand for biopharmaceutical products due to the rising prevalence of chronic diseases, such as cancer, diabetes, rheumatoid arthritis, psoriasis, and Crohn’s disease, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to ensure the safety and authenticity of biological products is favoring the market growth.  Apart from this, the increasing demand for biological safety testing to ensure the safety and efficacy of novel gene therapies for the treatment of various disorders, such as albinism, Angelman syndrome, ankylosing spondylitis, Apert syndrome, and cystic fibrosis, is providing an impetus to the market growth. Moreover, the widespread utilization of biotechnology-derived products in the healthcare industry for diagnosis, prevention, and treatment of diseases is propelling the market growth. Other factors, including increasing demand for single-use medical products, rising need for testing services, and extensive research and development (R&D) activities, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 7.16 Billion by 2027, exhibiting a CAGR of 12.55% during 2022-2027.

Market Summary:

  • On the basis of the product and services, the market has been divided into kits and reagents, instruments, and services.
  • Based on the test type, the market has been classified into endotoxin, sterility, cell line authentication and characterization, bioburden, residual host and contaminant detection, adventitious agent detection tests, and others.
  • On the basis of the application, the market has been divided into vaccine development, blood products testing, cellular and gene therapy, tissue and tissue-related products testing, and stem cell research.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others) Latin America (Brazil, Mexico and Others), and Middle East and Africa.?
  • The competitive landscape of the industry has also been examined, with some of the key players being Avance Biosciences, Charles River Laboratories, Creative Biogene, Eurofins Scientific, Lonza Group AG, Maravai LifeSciences, Pace Analytical Services Inc., Pacific BioLabs, Sartorius AG, SGS SA, ViruSure GmbH (Asahi Kasei Corporation) and WuXi Biologics.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Biological Safety Testing Market to Reach US$ 7.16 Billion by 2027, Impelled by Significant Growth in Pharmaceutical Industry
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More